Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cellsAgnieszka Korga-Plewko, Jarosław Dudka, Marta Ostrowska-Leśko et al.|BMC Pharmacology and Toxicology|2019Cited by 61
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatmentAgnieszka Korga-Plewko, Jarosław Dudka, Marta Ostrowska-Leśko et al.|FEBS Open Bio|2019Cited by 50
The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study resultsPiotr Witek, Jarosław Dudka, Agnieszka Korga-Plewko et al.|Cytotechnology|2016Cited by 48
Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin ToxicityAgnieszka Korga-Plewko, Jarosław Dudka, Monika Michalczyk et al.|Molecules|2020Cited by 40
Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide DerivativePaweł Kozyra, Monika Pitucha, Zbigniew Karczmarzyk et al.|Biomolecules|2022Cited by 30